Lampe Elisabeth O, Tandberg Julia I, Rishovd Anne-Lise, Winther-Larsen Hanne C
Center for Integrative Microbiology and Evolution, Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, 0316 Oslo, Norway.
Dis Aquat Organ. 2017 Mar 6;123(2):123-140. doi: 10.3354/dao03087.
The intracellular fish pathogen Francisella noatunensis remains an unsolved problem for aquaculture worldwide and an efficient vaccine is needed. In Francisella sp., IglC is an important virulence factor necessary for intracellular growth and escape from phagolysosomes. Deletion of the intracellular growth locus C (iglC) in Francisella sp. causes attenuation, but vaccine potential has only been attributed to ΔiglC from Francisella noatunensis ssp. orientalis, a warm-water fish pathogen. A ΔiglC mutant was constructed in the cold-water fish pathogen F. noatunensis ssp. noatunensis (Fnn), which causes francisellosis in Atlantic cod; the mutant was assessed in primary head kidney leucocytes from Atlantic cod. Fluorescence microscopy revealed reduced growth, while qPCR revealed an initial increase followed by a reduction in mutant genomes. Mutant-infected cod leucocytes presented higher interleukin 1 beta (il1β) and interleukin 8 (il8) transcription than wild-type (WT)-infected cells. Two doses of mutant and WT were tested in an adult zebrafish model whereupon 3 × 109 CFU caused acute disease and 3 × 107 CFU caused low mortality regardless of strain. However, splenomegaly developed only in the WT-infected zebrafish. Immunization with 7 × 106 CFU of Fnn ΔiglC protected zebrafish against challenge with a lethal dose of Fnn WT, and bacterial load was minimized within 28 d. Immunized fish had lower interleukin 6 (il6) and il8 transcription in kidney and prolonged interferon-gamma (ifng) transcription in spleens after challenge compared with non-immunized fish. Our data suggest an immunogenic potential of Fnn ΔiglC and indicate important cytokines associated with francisellosis pathogenesis and protection.
细胞内鱼类病原体诺氏弗朗西斯菌仍然是全球水产养殖中一个未解决的问题,因此需要一种有效的疫苗。在弗朗西斯菌属中,IglC是细胞内生长和从吞噬溶酶体逃逸所必需的重要毒力因子。弗朗西斯菌属中细胞内生长位点C(iglC)的缺失会导致毒力减弱,但疫苗潜力仅归因于来自东方诺氏弗朗西斯菌的ΔiglC,东方诺氏弗朗西斯菌是一种温水鱼类病原体。在冷水鱼类病原体诺氏弗朗西斯菌诺氏亚种(Fnn)中构建了ΔiglC突变体,Fnn会在大西洋鳕鱼中引起弗朗西斯菌病;该突变体在来自大西洋鳕鱼的原代头肾白细胞中进行了评估。荧光显微镜显示生长减少,而定量PCR显示突变体基因组最初增加,随后减少。与野生型(WT)感染的细胞相比,突变体感染的鳕鱼白细胞呈现出更高的白细胞介素1β(il1β)和白细胞介素8(il8)转录水平。在成年斑马鱼模型中测试了两剂突变体和WT,结果显示3×109 CFU会导致急性疾病,3×107 CFU无论菌株如何都会导致低死亡率。然而,脾肿大仅在WT感染的斑马鱼中出现。用7×106 CFU的Fnn ΔiglC免疫可保护斑马鱼免受致死剂量的Fnn WT攻击,并且在28天内细菌载量降至最低。与未免疫的鱼相比,免疫后的鱼在受到攻击后肾脏中的白细胞介素6(il6)和il8转录水平较低,脾脏中的干扰素-γ(ifng)转录时间延长。我们的数据表明Fnn ΔiglC具有免疫原性潜力,并指出了与弗朗西斯菌病发病机制和保护相关的重要细胞因子。